[go: up one dir, main page]

IL166023A0 - Oral dosage from comprising a liquid active agent formulation and controlling release thereof by an expandable osmotic composition - Google Patents

Oral dosage from comprising a liquid active agent formulation and controlling release thereof by an expandable osmotic composition

Info

Publication number
IL166023A0
IL166023A0 IL16602303A IL16602303A IL166023A0 IL 166023 A0 IL166023 A0 IL 166023A0 IL 16602303 A IL16602303 A IL 16602303A IL 16602303 A IL16602303 A IL 16602303A IL 166023 A0 IL166023 A0 IL 166023A0
Authority
IL
Israel
Prior art keywords
active agent
oral dosage
agent formulation
liquid active
controlling release
Prior art date
Application number
IL16602303A
Other languages
English (en)
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of IL166023A0 publication Critical patent/IL166023A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
IL16602303A 2002-06-28 2003-06-27 Oral dosage from comprising a liquid active agent formulation and controlling release thereof by an expandable osmotic composition IL166023A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39277402P 2002-06-28 2002-06-28
PCT/US2003/020422 WO2004002448A1 (en) 2002-06-28 2003-06-27 Oral dosage from comprising a liquid active agent formulation andcontrolling release thereof by an expandable osmotic composition

Publications (1)

Publication Number Publication Date
IL166023A0 true IL166023A0 (en) 2006-01-15

Family

ID=30000933

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16602303A IL166023A0 (en) 2002-06-28 2003-06-27 Oral dosage from comprising a liquid active agent formulation and controlling release thereof by an expandable osmotic composition

Country Status (15)

Country Link
US (1) US20040058000A1 (zh)
EP (1) EP1521570A1 (zh)
JP (1) JP2005533084A (zh)
KR (1) KR20050071376A (zh)
CN (1) CN1678291A (zh)
AR (1) AR040306A1 (zh)
AU (1) AU2003245738A1 (zh)
CA (1) CA2490412A1 (zh)
IL (1) IL166023A0 (zh)
MX (1) MXPA05000206A (zh)
NO (1) NO20050337L (zh)
NZ (1) NZ537492A (zh)
TW (1) TW200531708A (zh)
WO (1) WO2004002448A1 (zh)
ZA (1) ZA200500834B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007500558A (ja) * 2003-07-31 2007-01-18 アルザ・コーポレーシヨン 液状活性製剤の制御型放出のための透過抵抗性浸透エンジンおよび投薬剤形物
EP1667653A1 (en) * 2003-09-26 2006-06-14 Alza Corporation Dosage form for controlled release of an active agent formulation
KR20060092255A (ko) 2003-09-26 2006-08-22 알자 코포레이션 고도의 약물적재를 제공하는 약물코팅제 및 그의 제조방법
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US20070014847A1 (en) * 2005-07-05 2007-01-18 Ahmed Salah U Coated capsules and methods of making and using the same
FR2934805A1 (fr) 2008-08-07 2010-02-12 Inergy Automotive Systems Res Procede pour fixer un accessoire dans un corps creux en matiere plastique lors de son moulage.
WO2021176360A1 (en) * 2020-03-02 2021-09-10 Craft Health Pte Ltd Oral dosage forms for extended drug release
CN115490316B (zh) * 2022-01-24 2023-09-12 成都理工大学 一种可再利用的地下水营养物质缓释胶囊体

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US36472A (en) * 1862-09-16 Cttlvebt
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US5391381A (en) * 1987-06-25 1995-02-21 Alza Corporation Dispenser capable of delivering plurality of drug units
US5034229A (en) * 1988-12-13 1991-07-23 Alza Corporation Dispenser for increasing feed conversion of hog
US5223265A (en) * 1992-01-10 1993-06-29 Alza Corporation Osmotic device with delayed activation of drug delivery
WO1996010996A1 (en) * 1993-07-21 1996-04-18 The University Of Kentucky Research Foundation A multicompartment hard capsule with control release properties
GB9326267D0 (en) * 1993-12-23 1994-02-23 Scherer Corp R P Expulsion of material
US5614578A (en) * 1994-10-28 1997-03-25 Alza Corporation Injection-molded dosage form
AU5175998A (en) * 1996-11-15 1998-06-03 Alza Corporation Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems
US6245357B1 (en) * 1998-03-06 2001-06-12 Alza Corporation Extended release dosage form
US6551613B1 (en) * 1998-09-08 2003-04-22 Alza Corporation Dosage form comprising therapeutic formulation
US6174547B1 (en) * 1999-07-14 2001-01-16 Alza Corporation Dosage form comprising liquid formulation
DK1140012T3 (da) * 1998-12-17 2004-07-12 Alza Corp Omdannelse af væskefyldte gelatinekapsler til systemer til kontrolleret frigivelsessystemer ved flere coatinger
DK1140027T3 (da) * 1998-12-23 2006-02-27 Alza Corp Doseringsformer indeholdende poröse partikler
KR100738276B1 (ko) * 1999-12-09 2007-07-12 알자 코포레이션 항바이러스성 약제
EP1458353A1 (en) * 2001-12-19 2004-09-22 ALZA Corporation Formulation dosage form for the controlled delivery of ther apeutic agents
HUP0402451A3 (en) * 2001-12-19 2008-04-28 Alza Corp Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules

Also Published As

Publication number Publication date
ZA200500834B (en) 2006-04-26
WO2004002448A1 (en) 2004-01-08
TW200531708A (en) 2005-10-01
NO20050337L (no) 2005-01-21
MXPA05000206A (es) 2005-12-05
US20040058000A1 (en) 2004-03-25
EP1521570A1 (en) 2005-04-13
JP2005533084A (ja) 2005-11-04
NZ537492A (en) 2007-10-26
CN1678291A (zh) 2005-10-05
CA2490412A1 (en) 2004-01-08
KR20050071376A (ko) 2005-07-07
AR040306A1 (es) 2005-03-23
AU2003245738A1 (en) 2004-01-19

Similar Documents

Publication Publication Date Title
AU2003274680A8 (en) Modified release composition comprising coated micro matrix particles containing the high soluble active ingredient and a release controlling agent
AU2003274681A8 (en) Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
IL216704A (en) Micronutrients containing dictopiperazine salts and biologically active substance and used in the preparation of preparations for providing the active substance
IL157741A0 (en) Pharmaceutical compositions containing an antihyperplastic active agent
PL372084A1 (en) 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
AU2002217373A1 (en) Controlled release pharmaceutical formulation containing venlafaxine
IL164699A0 (en) Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
IL229510A0 (en) A dosage form containing pantoprazole as an active ingredient
TWI319318B (en) Modified release pharmaceutical formulation
IL162883A0 (en) Oral solid solution formulation of a poorly water-soluble active substance
WO2005063203A3 (en) Multiparticulate formulations for oral delivery
EP1569617A4 (en) PHARMACEUTICAL FORMULATION AEROSOL STABILIZED BY WATER
HUP0204202A3 (en) Ibuprofen containing active agent preparation, process for its preparation and pharmaceutical compositions containing it
HUP0301177A3 (en) Ion-strength independent sustained release pharmaceutical formulation
AU2003230189A1 (en) Oral controlled release pharmaceutical composition containing metaxalone as active agent
AU2001248336A1 (en) Controlled release oral solid forms containing mesalazine as active agent
IL165069A0 (en) Immediate release pharmaceutical formulation
HUP0303636A3 (en) Dihydronaphthalenederivative compounds and pharmaceutical compositions containing them as active ingredient
IL166023A0 (en) Oral dosage from comprising a liquid active agent formulation and controlling release thereof by an expandable osmotic composition
IL174336A0 (en) Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
IL173414A0 (en) Permeation-resistant osmotic engine and dosage form for controlled release of a liquid active agent formulation
PL1928436T3 (pl) Układ aplikacyjny dla zawierającego substancję czynną plastra i środka do regulacji podawania tej substancji
HU0303383D0 (en) Pellets containing active ingredient
GB0201607D0 (en) Formulation for the administration of medicinal substances
HK1094767A (zh) 控制釋放活性藥物製劑的劑型